The non-pharmacological option your patients have been waiting for.
OhmBody delivers clinically-documented menstrual support through tAN® (Transcutaneous Auricular Neurostimulation), with no prescription, no follow-up paperwork, and no hormones. A genuine adjunct for patients managing HMB, VWD, or hormone-intolerant conditions.
Science-Backed Clinical Results
The science behind tAN® is supported by two peer-reviewed clinical studies in participants with heavy menstrual bleeding. Together, they show meaningful reductions in blood loss, cycle duration, pain, gastrointestinal symptoms, and neurocognitive symptoms, with results strengthening across consecutive months of use.
The following statistics represent the average change observed across participants:
55%
Average reduction in menstrual blood loss
Women in the study experienced measurably lighter periods, with less blood loss across each cycle they used tAN®.¹ ²
68%
Decrease in overall menstrual symptoms
Women in the study reported fewer and less severe symptoms across their entire cycle, including pain, GI discomfort, and brain fog.²
62%
Decrease in pain-related symptoms
Women in the study reported less cramping, abdominal discomfort, and pain, with results strengthening over the second and third months of use.²
20%
Shorter period duration
Women in the study reported their periods ending sooner, with fewer days of bleeding each cycle.¹
“I’m excited to partner with OhmBody as they bring a truly innovative, drug-free option to women’s health. For decades, women dealing with heavy bleeding, endometriosis, PMDD, and perimenopause have had far too few effective, non-hormonal treatments. OhmBody’s vagus nerve stimulation technology offers a promising new way to support menstrual and hormonal well-being by working with women’s biology rather than against it. I’m thrilled to help advance this much-needed science.”
Dr. Holly Miller, MD, FACOG
Built For The Way You Already Practice
No prescription required
Recommend same-day at consultation. No prescribing workflow, no formulary review, no follow-up paperwork.
Platelet priming mechanism
Vagal stimulation activates splenic platelet management, and the only published non-pharmacologic device studied specifically in VWD patients.
Bioelectronic Support
Transcutaneous auricular neurostimulation (tAN®) engages the vagus and trigeminal nerves through the ear, non-invasive with no systemic effects.
HSA/FSA eligible
Patient-accessible through existing health savings accounts, removing a key cost barrier without practice involvement.
Partner with OhmBody and give your patients a drug-free solution they've been looking for.
Recommend OhmBody to your patients and earn commission automatically. No inventory, no minimums, no upfront costs. Your custom QR code sends patients directly to our site and tracks every purchase back to you.
Trackable per-clinic QR code · Monthly commission reports · Custom discount options available
Interested in supplying OhnBody directly?
Schedule 30 minutes with our team to learn more about wholesale opportunities.
Further Reading & References
- Czura CJ, Weyand AC, Baldwin MK, et al. “Transcutaneous auricular neurostimulation to reduce heavy menstrual bleeding in women with and without von Willebrand disease.” Frontiers in Medicine, Volume 12, 2025. https://doi.org/10.3389/fmed.2025.1664433
- Czura CJ, Weyand AC, Baldwin MK, et al. “A novel transcutaneous auricular neurostimulation electrode configuration for treatment of heavy menstrual bleeding: an open-label trial.” Bioelectronic Medicine, 2026. https://doi.org/10.1186/s42234-026-00203-1